首页 | 本学科首页   官方微博 | 高级检索  
     

RNA干扰CYP1B1基因沉默抑制多不饱和脂肪酸诱导的人乳腺癌MDA-MB-231细胞增殖
引用本文:刘蕾,王斌,糜漫天. RNA干扰CYP1B1基因沉默抑制多不饱和脂肪酸诱导的人乳腺癌MDA-MB-231细胞增殖[J]. 肿瘤, 2012, 32(6): 429-434
作者姓名:刘蕾  王斌  糜漫天
作者单位:第三军医大学营养与食品安全研究中心,重庆市营养与食品安全重点实验室,重庆市医学营养研究中心,重庆400038
基金项目:国家自然科学基金青年科学基金资助(编号:30901195)
摘    要:目的:探讨小干扰RNA (small interference RNA,siRNA)介导的细胞色素P450 1B1(cytochrome P-4501B1,GYP1B1)基因沉默对二十碳五烯酸(eicosapentaenoic acid,EPA)和花生四烯酸(arachidonic acid,AA)作用下乳腺癌MDA-MB-231细胞增殖的影响.方法:应用细胞计数试剂盒(cell counting kit-8,CCK-8)检测经EPA和AA处理后MDA-MB-231细胞的增殖情况.采用RNA干扰(RNA interference,RNAi)技术干扰CYP1B1的表达,随后应用荧光实时定量PCR (real-time fluorescence quantitative PCR,RFQ-PCR)和蛋白免疫印迹法检测转染效率,以及siRNA干扰后EPA和AA作用下MDA-MB-231细胞中CYP1B1和儿茶酚氧位甲基转移酶(catechol-O-methyltransferase,COMT)mRNA和蛋白的表达情况.采用CCK-8法检测siRNA干扰后EPA和AA作用下MDA-MB-231细胞的增殖情况.结果:EPA处理组的MDA-MB-231细胞数明显少于对照组,而AA处理组的MDA-MB-231细胞则明显多于对照组(P<0.05).转染CYP1B1 siRNA的MDA-MB-231细胞中,CYP1B1 mRNA和蛋白的表达均有所下降,而COMT mRNA和蛋白的表达水平则有所上升.CYP1B1 siRNA转染的MDA-MB-231细胞的增殖能力下降,且EPA处理组的MDA-MB-231细胞数明显多于阴性对照组(P<0.05).结论:CYP1B1基因沉默能够抑制MDA-MB-231细胞的增殖,逆转EPA对细胞增殖的抑制作用.EPA可能通过调节CYP1B1的表达来抑制乳腺癌细胞的增殖.

关 键 词:乳腺肿瘤  RNA,小分子干扰  类固醇11-β-羟化酶  儿茶酚-O-甲基转移酶  脂肪酸类,不饱和

Small interference RNA-mediated CYP1B1 gene silencing inhibits the proliferation of human breast cancer MDA-MB-231 cells induced by polyunsaturated fatty acids
LIU Lei , WANG Bin , MI Man-tian. Small interference RNA-mediated CYP1B1 gene silencing inhibits the proliferation of human breast cancer MDA-MB-231 cells induced by polyunsaturated fatty acids[J]. Tumor, 2012, 32(6): 429-434
Authors:LIU Lei    WANG Bin    MI Man-tian
Affiliation:Research Center for Nutrition and Food Safety,Third Military Medical University,Chongqing Key Laboratory of Nutrition and Food Safety,Chongqing Medical Nutrition Research Center,Chongqing 400038,China
Abstract:Objective:To investigate the effect of CYP1B1(cytochrome P-450 1B1) gene silencing induced by small interference RNA(siRNA) on the proliferation of MDA-MB-231 cells treated with EPA(eicosapentaenoic acid) and AA(arachidonic acid).Methods:The proliferation of MDA-MB-231 cells treated with EPA or AA was detected by CCK-8(cell counting kit-8) assay.The expression of CYP1B1 was interfered by RNAi(RNA interference) technique.The transfection efficiency was examined by real-time fluorescence quantitative PCR(RFQ-PCR) and Western blotting,respectively.The expression levels of CYP1B1 and COMT(catechol-O-methyltransferase) mRNAs and proteins in MDA-MB-231 cells interfered with siRNA and treated with EPA or AA were determined by RFQ-PCR and Western blotting,respectively.The viability of breast cancer MDA-MB-231 cells interfered with siRNA and treated with EPA or AA was detected by CCK-8 assay.Results:The cell number of EPA-treated group was lower while the cell number of AA-treated group was higher than that of the control group(P<0.05).The expression levels of CYP1B1 mRNA and protein were decreased in MDA-MB-231 cells transfected with CYP1B1 siRNA,while the expression levels of COMT mRNA and protein were increased.The proliferation of MDA-MB??-231 ls transfected with CYP1B1 siRNA was inhibited,and the number of MDA-MB??-231 cells treated with EPA was significantly higher than that of the negative control group(P<0.05).Conclusion:CYP1B1 gene silencing inhibits the proliferation of MDA-MB-231 cells and reverses the inhibitory effect of EPA on the cell proliferation.EPA probably inhibits the cell proliferation through regulating the expression of CYP1B1 in breast cancer.
Keywords:Breast neoplasms  RNA,small interfering  Steroid 11-beta-hydroxylase  Catechol-O-methyltransferase  Fatty acids,unsaturated
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号